Detalhe da pesquisa
1.
Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
Eur J Nucl Med Mol Imaging
; 48(7): 2110-2120, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590274